Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Fulgent Genetics, Inc. (NASDAQ: FLGT).

Full DD Report for FLGT

You must become a subscriber to view this report.


Recent News from (NASDAQ: FLGT)

Fulgent Genetics' (FLGT) CEO Ming Hsieh on Q1 2018 Results - Earnings Call Transcript
Fulgent Genetics (FLGT) Q1 2018 Earnings Conference Call May 7, 2018 4:30 PM ET Executives Nicole Borsje - Investor Relations Ming Hsieh - Chairman, President and Chief Executive Officer Paul Kim - Chief Financial Officer Analysts Erin Wright - Credit Suisse Presentation...
Source: SeekingAlpha
Date: May, 07 2018 22:47
Fulgent Genetics Reports First Quarter 2018 Financial Results
First Quarter 2018 Results : Revenue of $4.7 million, up 9% sequentially Billable tests delivered grew 10% sequentially to 4,621 GAAP loss of $1.9 million, or $0.11 per share Non-GAAP loss of $1.2 million, or $0.06 per share Adjusted EBITDA loss of $1.1 million TEMPLE CITY, Cali...
Source: GlobeNewswire
Date: May, 07 2018 16:05
Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018
TEMPLE CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2018 financial results after the market closes on Monday, May 7, 2018. The co...
Source: GlobeNewswire
Date: April, 23 2018 08:00
Fulgent Genetics: Can Ming Hsieh Do It Again?
It's not every day I find a microcap stock being led by a founder as wealthy as Ming Hsieh. In 2006 he had a net worth of $1.6 billion, as shares of the company he founded Cogent System reached all-time highs. In 2010 Cogent was sold to 3M (MMM), in a sale which netted him around $376 million...
Source: SeekingAlpha
Date: March, 19 2018 09:24
Premarket analyst action - healthcare
Recro Pharma (NASDAQ: REPH ) resumed with Outperform rating and $19 (111% upside) price target at Oppenheimer. More news on: Recro Pharma Inc, Health Insurance Innovations, SurModics, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: March, 01 2018 08:20
Fulgent Genetics' (FLGT) CEO Ming Hsieh on Q4 2017 Results - Earnings Call Transcript
Fulgent Genetics (FLGT) Q4 2017 Results Earnings Conference Call February 28, 2018, 04:30 PM ET Executives Nicole Borsje - IR Ming Hsieh - CEO Paul Kim - CFO Analysts Bill Quirk - Piper Jaffray Andrew Cooper - Raymond James Yi Chen - H.C. Wainwright Presentation ...
Source: SeekingAlpha
Date: February, 28 2018 21:22
Fulgent Genetics misses by $0.05, misses on revenue
Fulgent Genetics (NASDAQ: FLGT ): Q4 EPS of -$0.06 misses by $0.05 . More news on: Fulgent Genetics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: February, 28 2018 16:22
Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results
Fourth Quarter of 2017 Results : Revenue of $4.3 million GAAP loss of $1.8 million, or $0.10 per share Non-GAAP loss of $1.0 million, or $0.06 per share Adjusted EBITDA loss of $952,000 Full Year 2017 Results : Revenue of $18.7 million GAAP loss of $2.7 million, or $0.15 per...
Source: GlobeNewswire
Date: February, 28 2018 16:05
Representatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare Conference
TEMPLE CITY, Calif., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief Financial Officer Paul Kim are scheduled to pa...
Source: GlobeNewswire
Date: February, 23 2018 08:00
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2017 financial results after the market closes on Wednesday, Fe...
Source: GlobeNewswire
Date: February, 13 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-183.853.953.953.71115,724
2018-05-173.853.953.953.71115,724
2017-02-0312.0011.9912.1710.6093,916
2017-02-0212.8912.1912.8912.0020,327
2017-02-0113.0512.9013.34512.7058,376

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-252553,9616.4378Cover
2018-05-243916423.7805Cover
2018-05-232033,2416.2635Cover
2018-05-2210060016.6667Cover
2018-05-2111032034.3750Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on FLGT.


About Fulgent Genetics, Inc. (NASDAQ: FLGT)

Logo for Fulgent Genetics, Inc. (NASDAQ: FLGT)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $67,894,106 - 05/11/2018
  • Issue and Outstanding: 17,866,870 - 03/01/2018

 


Recent Filings from (NASDAQ: FLGT)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 07 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 13 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 28 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 06 2017
Filing Type: CT ORDERFiling Source: edgar
Filing Date: September, 26 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2017

 

 


Daily Technical Chart for (NASDAQ: FLGT)

Daily Technical Chart for (NASDAQ: FLGT)


Stay tuned for daily updates and more on (NASDAQ: FLGT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: FLGT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in FLGT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of FLGT and does not buy, sell, or trade any shares of FLGT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/